Skip to content

Efficacy of Therapeutic Exercise vs. Treatment of Myofascial Trigger Points.

Efficacy of Therapeutic Exercise vs. Treatment of Myofascial Trigger Points in Shoulder Tendinopathies: Randomised Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06241404
Enrollment
80
Registered
2024-02-05
Start date
2023-10-01
Completion date
2024-01-15
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Tendinopathy

Keywords

shoulder tendinopathy, supraspinatus, infraspinatus, physiotherapy techniques, therapeutic exercise, trigger points

Brief summary

Background: Shoulder pain commonly affects the general population, with rotator cuff tendinopathy being the most common cause. the most common cause, with rotator cuff tendinopathy diminishing function and quality of life, leading to a major socio-economic impact. quality of life, leading to a major socio-economic impact. As a result, there are two treatment approaches with potential effectiveness: therapeutic exercise (TE) and myofascial trigger point treatment (TMT). trigger point treatment (TTP). Objective: The main objective of this randomised clinical trial is to determine the efficacy of ET versus treatment of MTPs in shoulder tendinopathies. Methods: For this study, 20 participants were randomly divided into two groups: a ET group, with which a 10-exercise programme was initiated (n = 10), and a PGM group which was given an intervention protocol (n = 10). intervention protocol (n = 10). Both received a total of 10 sessions. Pain intensity pain intensity, pressure pain threshold (PPT) and range of motion (ROM) were assessed before starting and after 10 sessions. and after 10 sessions.

Interventions

patients who have been treated for shoulder tendinopathy by trigger point therapy

PROCEDUREExercise therapy

patients who have been treated for shoulder tendinopathy by exercise therapy

Sponsors

Universidad Católica de Ávila
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Signed informed consent form. * Patients diagnosed by an orthopaedic surgeon with shoulder tendinopathy. tendinopathy. * Symptoms of shoulder pain lasting more than 3 months. * Pain on Jobe, Patte and infraspinatus assessment manoeuvres (highlighting abduction and abduction and external rotation).

Exclusion criteria

* Previous shoulder surgery. * Radiating (non-referred) pain from cervical radiculopathy. * Shoulder pain associated with other diagnoses (Examples: retractile capsulitis, subacromial syndrome, tendon rupture, posterosuperior conflict, etc.). subacromial syndrome, tendon rupture, posterosuperior conflict, etc). * Patients with multiple pathologies. * Patients with neurological disorders.

Design outcomes

Primary

MeasureTime frameDescription
Range of motionAt the end of Session 10 (each Session is 7 days)measurement of shoulder range of motion
pain intensityAt the end of Session 10 (each Session is 7 days)measured on a VAS scale where 0 is the minimum and 10 is the maximum.

Secondary

MeasureTime frameDescription
pressure pain thresholdAt the end of Session 10 (each Session is 7 days)measured by algometer

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026